A Study of Synthesis and Superoxide Dismutase Activity of Phthalicacid [Bis(Benzyloxy)Ethyl]Ester
Synthesis and characterization of a new ligand and its copper complex with superoxide dismutase activity
by Anupama .*, Dr. Parveen .,
- Published in Journal of Advances and Scholarly Researches in Allied Education, E-ISSN: 2230-7540
Volume 12, Issue No. 2, Jan 2017, Pages 790 - 796 (7)
Published by: Ignited Minds Journals
ABSTRACT
In this paper, we report the amalgamation of another ligand phthalicacid[bis(benzyloxy)ethyl] ester by the response of phthalic anhydride and ethylene glycol. The ligand was portrayed by FTIR, HNMR and Mass spectra. Binuclear Copper (II) complex of the ligand bound to four acetic acid derivation particles was orchestrated and described by electronic spectra, FTIR spectra, EPR spectra, thermo gravimetric (TGA) investigation and electrochemical examinations. The superoxide rummaging action of the complex is additionally announced.
KEYWORD
synthesis, superoxide dismutase activity, ligand, phthalicacid [bis(benzyloxy)ethyl] ester, phthalic anhydride, ethylene glycol, FTIR, HNMR, Mass spectra, Binuclear Copper (II) complex, acetic acid derivation particles, electronic spectra, EPR spectra, thermo gravimetric (TGA) investigation, electrochemical examinations
INTRODUCTION
Cu is a basic micronutrient required by all types of life and include in an assortment of organic procedures viz., embryonic advancement, mitochondrial breath, control of hemoglobin levels and also hepatocyte and neuronal capacities. Being a change metal, Cu gets organically changed over between various redox states to be specific oxidized Cu (II) and diminished Cu (I). This extraordinary trait has made Cu metal to get showed as an essential synergist co-factor for an assortment of metabolic responses in natural frameworks (Pederson, 1973). Buildings of Cu in oxidation state +2 are likewise naturally noteworthy in view of their cell reinforcement and against free extreme movement (Fridovich, 1978, (Mizushima, et. al., 1992). They involve a class of potential mitigating drugs with lessened symptoms, and their method of activity is ascribed to their checked superoxide dismutase (SOD) mimetic action. Binuclear Cu (II) edifices are potential models for various vital organic frameworks containing couple locales (Tabbi, et. al., 1998) and have been contemplated widely ((Halliwell and Gutteridge, 1989. Vogtle and Webber, 1986. Huber, 1980. Liczmanski, 1994. Brigelius, et. al., 1974. Goldstein and Czapski, 1983) In addition, the Cu (II) edifices of multidentate Schiff base ligands have assumed an essential job in the improvement of coordination science (Underhill, et. al., 1987. Burry, et. al., 1989. Bijloo, et. al., 1990). The bimetallic Cu (II) buildings additionally have pulled in much consideration in magneto science because of the turn communication between the copper (II) focuses. Superoxide dismutase (SOD) is a compound associated with shielding organic cells from the dangerous impacts of superoxide (Bhirud and Srivastava, 1990). In view of the metal particles present in the dynamic site SODs have been separated into - Cu-Zn-SOD, Mn-SOD and Fe-SOD out of which the first is found in warm blooded creatures (Goldstein, et. al., 1990). Lacking level of SOD focus in human body is one reason behind infections and scatters like - diabetes, ischemia, waterfall, Parkinson's sickness, diseases and so forth (Bhirud and Srivastava, 1991. Labuda, et. al., 1991). Supplementation of cell reinforcement compounds ought to be a piece of the treatment yet organization of these proteins through oral or intraperitonial courses is seriously limited because of their fast corruption and short life time in natural frameworks (Underhill, et. al., 1993). Low atomic weight metal conjugates of SOD give preferences over the characteristic catalysts in regard of their capacity in intersection the phone films, offering no immunogenicity, having longer life-time of the dynamic structures, plausibility of oral organization and similar minimal effort. Since copper goes about as the dynamic focus in CuZnSOD,a number of Cu edifices have been composed and blended as SOD demonstrate buildings to give important bits of knowledge into the structure and reactant capacity of the Cu, Zn-SOD
Cu(II)/Cu(I) can impact the SOD - like movement, Small metal edifices having great superoxide rummaging action are potential hopeful in such manner. Cu (II) edifices with Schiff base ligands got from different aldehydes and ketones have been accounted for to mirror SOD action (Iakovidou, et. al., 2001). Different models in such manner incorporates - imidazole connected Cu (II) buildings (Patole, et. al., 2001), planar Cu (II) complex on expansion of a base, for example, N-methyl imidazole or pyridine (Maurer, et. al., 2002), curcumin edifices of Cu(II) (Cowly, et. al., 2002) and so on. There is additionally report that the SOD movement of Cu (II) edifices with Schiff base ligands of salicylaldehyde semicarbazone could be tuned by heterocyclic bases pyridine and N-methyl imidazole (Ferrari, et. al., 2002).
METHODOLOGY
Phthalic anhydride and ethylene glycol were acquired from Merck and Cu (II) acetic acid derivation monohydrate was obtained from Loba Chemie. All dissolvable were purged by standard strategy.
1. Synthesis
2. Phthalic corrosive bis(benzyloxy)ethyl ester (L) and its portrayal synthesis 20 mmol (2.96 g) phthalic anhydride was taken in a mortar and crushed. 10 mmol (0.6 mL) of ethylene glycol was included drop savvy with steady mixing. The response blend was warmed to 60 oC and 2-3 drops of pyridine was included. The blend was chilled to acquire a white item which was then recrystallised from methanol. The engineered way for the ligand (L) has been appeared in plan 6.1 beneath
Scheme 1: Synthetic path for the ligand (L)
Yield 85%, Melting Point = 115 oC FTIR analysis of L: FTIR spectrum of L was recorded in KBr pallet. Peaks were observed at 3404 cm-1 due to uO-H, 2920.7 cm-1 due to uC-H, 1627 cm-1 due to uC=O, 1289.4 cm-1 due to uC-O, 1391.3 cm-1 due to u-CH2-, 756 cm-1 and 705 cm-1 due to aromatic C-H out of plane bending. LC-MS analysis of L: LCMS of L was recorded in acetonitrile. The m/e value for the molecular peak 1HNMR of L: *HNMR of L was recorded in CDCl3. Chemical shifts, 8 in ppm, were observed at 7.72 (2H, t, j = 5.1 Hz); 7.56 (2H, t, j = 5.7 Hz); 7.44 (4H, d, j = 4.0 Hz); 4.52 (4H, s)
Figure 1: FTIR spectrum of L in KBr Figure 2: LC-MS spectrum of L in Ch2CN. Table 1: Assigned molecular fragment of L in LC-MS
Figure 3: *HNMR of L in CDCh Copper (II) phthalicacid [bis(benzyloxy)ethyl]ester synthesis
Cu (CH3COO) 2,1 mmol (0.199 g) was broken down in 10 mL methanol. An answer of L, arranged by dissolving 1 mmol (0.380 g) into 10 ml of methanol, was included drop shrewd with vivacious mixing. The mixing was proceeded for three hours till dim blue hasten was gotten. The accelerate was washed with diethyl ether and dried in air. The compound was recrystallised from acetonitrile and methanol blend to get blue hued gems.
RESULTS
1. UV/vis and FTIR investigation
The UV/vis spectra of the complex were recorded in acetonitrile and an expansive band was seen at Xmax 714 nm because of d ^ d change starting at Cu (II) (Fig.7.4). The elimination coefficient (s) was ascertained to be 709.68 Lmol-1cm-1. In the event of the ligand, a solid absorbance top was seen at 274nm which vanished if there should be an occurrence of the complex. FTIR spectra for the complex blended in KBr indicated tops at 2966.5 cm-1 (u C-H of C6H5); 756 cm-1 and 705cm-1 (C-H out of plan vibration for C6H5); 1631.7cm-1 (u C=O); 1400cm (usymm. COO 1589.3 cm (uasymm. COO-); 3441 cm-1 (UO-H). The u C=O band for the carbonyl gathering was watched nearly similarly situated in both the ligand and its mind boggling, in this way showing the non inclusion of the C=O bunch in complex development with the metal particle. The presence of uCOO-method of vibration in the vibrational spectra of complex demonstrates the official of acetic acid derivation particles.
Figure 4: UV/vis spectrum of copper (II) phthalicacid [bis(benzyloxy)ethyl]ester (a) 0.0009M and (b) 0.00009M Figure 5: FTIR specture of copper (II) phthalicacid [bis(benzyloxy)ethyl]ester
The calculated value of g tensor parameter was g|| = 2.06 and gi = 2.03. Hence g|| > gi > 2.003 which reveals that dx2-y2 is the ground state (Sun, et. al., 2000). The value of G was calculated to be 2.04 which are less than 4 indicates considerable exchange interaction between the copper centres (Patel, et. al., 2005). From the observed values, it is clear that g| > gi (2.06 >2.03), which suggests elongated octahedral structure
Figure 6: EPR spectra of copper (II) phthalicacid [bis(benzyloxy) ethyl]ester 2. Study of EPR spectroscopy
The X-band EPR spectra of the complex was recorded as the polycrystalline examples at room temperature (Fig.7.6). The giso esteem and geometric parameter G i.e. the estimation of trade association between the copper focuses was assessed by utilizing the articulation (Jouad, et. al., 2002):
3. Magnetic moment of copper (II) phthalicacid [bis(benzyloxy) ethyl]ester
Attractive vulnerability information for the complex were gathered at room temperature. The attractive minute incentive for the homobinuclear copper edifices was observed to be 1.65 BM. This low estimation of attractive minute qualities for coupled Cu (II) particles recommends antiferromagnetic communication between Cu (II) focuses. 4. Thermo gravimetric investigations of copper (II) phthalicacid[bis (benzyloxy) ethyl]ester: Thermogravimetric weight reduction bend for the complex has been appeared in Fig. 6.7. The weight reduction profile as a component of temperature demonstrated two stages at ca. 210 oC and 310 oC. It is notable that acetic acid derivations separate in the temperature go 200 oC to400 oC. The weight reduction profile has been broke down according to revealed writing (Chiari, et. al., 2001). The misfortune in weight in the initial step is ca. 59.50%, or, in other words fit to 4CH3COO + 0.52 L. The second drop of weight (24.48%) could be fitted to 0.19 L. The rest of the division of L represents the two oxygen molecules spent in the development of the last item polymeric (CuO2)n. This thermo gravimetric investigation results solely bolsters the structure of the mind boggling as delineated in Scheme 6.2.
5. Mass Spectroscopy study for copper (II) phthalicacid [bis(benzyloxy)ethyl]ester: The ESI-MS spectra were measured in order to confirm the composition and purity of the compound under investigation. The spectra displayed the molecular ion peak of complex at m/z 717 which is attributable to [M+1] +. The ESI-MS spectrum of complex has been shown in Fig. 6.8. The calculated value of molecular mass of complex is 721
Figure 8: ESI-MS spectra of copper (II) phthalicacid[bis(benzyloxy)ethyl]ester
Cyclic voltammogram of the 1.0 mM arrangement of the complex in acetonitrile was endeavored on Pt plate anode. A sharp irreversible decrease crest was seen at - 0.005 V versus Ag-AgCl and sweep rate 0.100 Vs-1 (Fig.6.9). This perception is evident on the grounds that in the complex the Cu (II) particle is bound to four hard oxygen benefactor destinations which make the co-appointment exceptionally steady. On decrease of Cu (II) into Cu (I) or, in other words the four oxygen benefactor are not any more reasonable and the complex is relied upon to separate. Subsequently the irreversible decrease crest with no oxidation partner was watched
Figure 9: Cyclic voltammogram of copper (II) phthalicacid[bis(benzyloxy)ethyl]ester in CH3CN. Working electrode: Pt disc.reference electrode: Ag-AgCl supporting electrolyte: TBAB
Scheme: Structure of Nitroblue tetrazolium (NBT)
The SOD movement of copper (II) phthalicacid[bis(benzyloxy)ethyl]ester has been examined by the technique for NBT decrease utilizing KO2-. as the wellspring of superoxide radical [29]. The NBT is yellow in shading. Upon decrease shaded arrangement was estimated promptly at 560 nm against a proper clear. One unit of SOD action (IC50 esteem) was characterized as the test substance required for half restraint of NBT decrease by the superoxide anion (Ferrari, et. al., 2002). A direct connection was gotten between the centralization of the copper complex and the hindrance of the superoxide particle. The 100% of superoxide movement relates to a measure performed without complex. With the end goal to decide the grouping of the complex required to yield half hindrance of the response, we plotted the level of restraint against the metal focus and the got IC50 esteem was 8.6x10-6 M (the IC50 estimation of the local chemical is 0.72x 10-7 M (Wilkinson & Gillard, 1987). This IC50 esteem is littler than many announced ones e.g. IC50 esteems are found in the range 3.0x10-5 M to 3.7x10-5 M for Cu (II) edifices of amino acids (Pederson, 1973); 9.9x10-5 M to 2.4x10-4 M for the Cu (II) buildings with straightforward dipeptides (Mizushima, et. al., 1992). It has been recommended that just buildings with IC50 esteems beneath 20x10-6 M may turn out to be clinically fascinating (Tabbi, et. al., 1998). IC50 esteem for this complex has been contrasted and other announced one in Table 7.2. Accordingly, copper (II) phthalicacid[bis(benzyloxy)ethyl]ester satisfies this necessity and shows up as an intriguing plausibility for further examinations in the field of SOD-mimetic medications.
Figure 10: Plot of percentage inhibition against molar concentration of copper (II) phthalicacid[bis(benzyloxy)ethyl]ester
CONCLUSION
Another ligand framework phthalicacid[bis (benzyloxy)ethyl]ester got from phthalic anhydride and ethylene glycol has been blended and portrayed. The ligand ties to two Cu (II) particles giving another bimetallic Cu (II) complex which indicate critical superoxide dismutase action. This compound has the likelihood for further examinations in the field of SOD-mimetic medications as it satisfies all the basic prerequisites in such manner.
REFERENCES
1. T. C. Pederson and S. D. (1973). Aust Biochemical and Biophysical Exploration Correspondences 52, p. 1071. 2. I. Fridovich, Science 201 (1978). 825 and D. Salvemini and R. Botting Medication News Perspect.6, p. 274. 3. Y. Mizushima, R. Igarshi, C. G. Wermuth, N. Koga, H. Kinig, and B. W. Metcalf (1992). Restorative Science for the 21st Century, Black-Well Logical Distributions, Oxford, UK. 4. G. Tabbi, T Nauser, W. H. Koppenol, and J. Reedijk (1998). European Diary of Inorganic Science 12, p. 193. 5. B. Halliwell and J. M. C. Gutteridge (1989). Free Radicals in Science and Prescription, Clarendon Press, Oxford, UK, second version. 6. A. Gartner and U. weser in Topicsin Current Chemistry, F.Vogtle and E. Webber Eds. (1986). Springer, Berlin 132, p. 1. 7. W. Huber (1980) M.G.P. Saifer and L. D. Williams in Natural and Clinical Parts of Superoxide Dismutase, W.H. Balustrade and 8. A. E. Liczmanski, H. (1994). J. Hartmann, and U. Weser Announcement of the Clean Institute of Sciences 42, p.291. 9. R. Brigelius , R. Spottl, W. Bors, E. Lengefelder, M. Saran, and U. Weser (1974). FEBS Lett. 47, p. 72. 10. S. Goldstein and G. Czapski (1983). J. Am. Chem. Soc. 105, p. 7276. 11. A. Cover, A. E. Underhill, D. R. Kemp, N. J. O'Shea, J. P. Smith, and P. S. Gomm (1987). Inorg.Chim. Acta 138, p. 85. 12. A. Burry, A. E. Underhill, M. B. Armada, P. J. Keymer, A. Stevens, and P. S. Gomm (1989). Inorg. Chim. Acta 158, p. 181. 13. C. J. Bijloo, H. Van der Goot, A. Bast, and H. Timmerman (1990). J. Inorg. Biochem. 40, p. 237. 14. R. G. Bhirud and R.S. Srivastava (1990). J. Inorg. Biochim 40, p. 331. 15. S. Goldstein, G. Czapski, and D. Meyerstein (1990). J. Amer. Chem. Soc. p. 112. 16. R. G. Bhirud and T. S. Srivastava (1991). Inorg. Chim. Acta 125, p. 6489. 17. J. Labuda, J. Kratsmar-Smogrovic, M. Vanickova, and L. Gazova (1991). Chem. Papers 45, p. 605. 18. A. E. Underhill, S. A. Bougourd, M. L. Flugge, S. E. Storm, and P. S. Gomm (1993). J. Inorg. Biochem. 52, p. 273. 19. L. L. Costanzo, G. Deguidi, S. Giuffrida, E. Rizzarelli, and G. Vecchio (1993). J. Inorg. Biochem. 50, p. 273. 20. Z. Iakovidou, A. Papageorgiou, M A Demertzis, E Mioglou, D Mourelatos, A Kotsis, P N Yadav and D. Kovala-Demertzi (2001). Hostile to Malignancy Medications 12, p. 65. 21. J. Patole, S. Dutta, S. Padhye and E. Sinn (2001). Inorg Chim Acta 318, p. 207. 22. R. I. Maurer, P. J. Blower, J. R. Dilworth, C. A. Reynolds, Y. Zheng and G. E. DMullen (2002). J. Med Chem 45, p. 1420.
Soc. 124, p. 5270. 24. M. B. Ferrari, F. Bisceglie, G. Pelosi, M. Sassi, P. Tarasconi, M. Cornia, S. Capacchi, R. Albertini and S. Pinelli (2002). J Inorg Biochem 90, p. 113. 25. E. M. Jouad, X. D. Thanh, G. Bouet, S. Bonneau and M. A. Khan (2002). Anticancer Res. 22, p. 1713. 26. W-Y. Sun, J. Fan, T. Okamura, N. Ueyama (2000). Inorg. Chem.Commun. 3, p. 541. 27. R. N. Patel, N. Singh, K. K. Shukla, V. L. N. Gundla, U. K. Chauhan (2005). Spectrochim. Acta A 61, p. 2603. 28. A. S. Chiari, P. E. Daon, B. M. Hoffman, J. A. Ibers (2001). Angew. Chem. Intl. Ed. Engl. 40, p. 244. 29. J. K. Swearingen (2001). D. X. West Trans. Met. Chem. 26, p. 252. 30. G. Wilkinson, R. D. Gillard (1987). J. A. Mc Cleverty Far reaching Coordination Science, vol. 2, Elsevier, Oxford. 31. T. C. Pederson (1973). S. D. Aust Biochim. Biophys. Res. Commun. 52, p. 1071. 32. Y. Mizushima, R. Igarshi, C. G. Wermuth, N. Koga, H. Kinig, B. W. Metcalf (1992). Therapeutic Science for the 21st Century, Dark well Logical Distributions, Oxford, p. 331. 33. G. Tabbi, T. Nauser, W. H. Koppenol (1998). J. Reedijk Eur. J. Inorg. Chem. 12, p. 1939. 34. B. Halliwell and J. M. C. Gutteridge (1989). Free Radicals in Science and Medication, second edn., Clarendon Press, Oxford. 35. A. E. Liczmanski, H. J. Hartmann (1994). U. Weser Bull. Pol. Acad. Sci. Biol. Sci. 42, p. 291.
Corresponding Author Anupama*
Research Scholar of OPJS University, Churu, Rajasthan